ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

Dinoprost

HCID 5280363
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
23518-25-4
標準SMILES
CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)C[C@H]1O
InChIKey
PXGPLTODNUVGFL-YNNPMVKQSA-N
分子式
C20H34O5
平均分子量
354.5 g/mol
単同位体質量
354.24062418

概要

Prostaglandin F2alpha is a prostaglandins Falpha that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9, 11 and 15. It is a naturally occurring prostaglandin used to induce labor. It has a role as a mouse metabolite and a human metabolite. It is a monocarboxylic acid and a prostaglandins Falpha. It is a conjugate acid of a prostaglandin F2alpha(1-).

名称と識別子

優先名称
Dinoprost
IUPAC
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid
英語名
(+-)-PGF2-alpha
分子式
C20H34O5
分子量
354.48

名称と別名

dinoprostprostaglandin F2alphaProstaglandin F2aPGF2alphaamoglandinEnzaprostpanacelanDinoprostaProtamodinProstaglandin F2-alphal-PGF2-alphaPGF2a
名称をさらに表示
PIGF-2(+-)-PGF2αdl-Prostaglandin F2αProsta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9α,11α,13E,15S)-(±)-(5Z,9α,11α,13E,15S)-(±)-9,11,15-Trihydroxyprosta-5,13-dien-1-oic acid (ACI)Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9α,11α,13E,15S)-(+-)-5-Heptenoic acid, 7-[3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-, (+-)- (8CI)
PGF-2alphaPGF2-alphaDinoprostumProsmonl-Prostaglandin F2-alphaProstarmon FProstin F2alphaProstin F2-alpha

データベース識別子

CAS
23518-25-4、551-11-1

物性

構造計算による物性

XLogP
2.7
極性表面積
98 Ų
水素結合供与体数
4
水素結合受容体数
5
回転可能結合数
12
重原子数
25
形式電荷
0
複雑度
432

実験および物理化学的性質

DrugsPharmaceuticals -> Listed in ZINC15
LipidsFatty Acyls [FA] -> Eicosanoids [FA03] -> Prostaglandins [FA0301]
LogP2.72
Color/FormNATURAL FORM, CRYSTALS
Solubility · 2 件

SOL IN WATER 200 MG/ML /DINOPROST TROMETHAMINE/

FREELY SOL IN METHANOL, ABSOLUTE ETHANOL; FREELY SOL IN ETHYL ACETATE, CHLOROFORM; SLIGHTLY SOL IN WATER

Animal DrugsPharmaceuticals -> UK Veterinary Medicines Directorate List
Melting Point25-35 °C
Optical RotationSPECIFIC OPTICAL ROTATION: +23.5 DEG @ 25 °C/D (1 G IN 100 ML TETRAHYDROFURAN)
Stability/Shelf Life · 3 件

STABLE FOR 2 YR IN LIGHT RESISTANT CONTAINERS @ 5-15 °C

DEGRADES IN 1 WK WHEN EXPOSED TO SUNLIGHT OR IN 3 MO @ 40 °C

STABLE IN LIGHT, AIR, & HEAT /DINOPROST TROMETHAMINE/

Collision Cross Section · 3 件

191.3 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Calculation: Single Field; Dataset: Oxylipins]

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P264, P264+P265, P270, P280, P301+P317, P305+P351+P338, P308+P316, P318, P319, P321, P330, P337+P317, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 39 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory InformationDinoprost: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Hazard Classes and CategoriesAcute Tox. 4 (100%)

毒性情報

InteractionsCONTRACTIONS IN RESPONSE TO PROSTAGLANDIN F2ALPHA IN HUMAN ISOLATED BRONCHIAL MUSCLE ARE INHIBITED BY FENAMATES, PHENYLBUTAZONE, &, LESS POTENTLY, ASPIRIN.
Human Toxicity Excerpts · 5 件

INTRADERMAL INJECTION OF.../PROSTAGLANDIN F2ALPHA/ IN MAN CAUSES "WHEAL & FLARE."

SIDE EFFECTS ATTENDING USE OF PROSTAGLANDINS IN SECOND & THIRD TRIMESTER & @ TERM ARE CAUSED BY THEIR STIMULATORY ACTION ON SMOOTH MUSCLE OF ALIMENTARY TRACT, THAT IS, NAUSEA, VOMITING, & DIARRHEA. /PROSTAGLANDINS/

CERVICAL OR LOWER UTERINE LACERATION OR RUPTURE, WITH RETENTION OF PLACENTA & HEMORRHAGE, IS PERHAPS MOST IMPORTANT DANGER WITH USE...FOR 2ND-TRIMESTER ABORTION. ... FEVER, HYPOTENSION & SYNCOPE, HYPERTENSION, HEADACHE, & PAIN & ERYTHEMA @ SITE OF INJECTION OCCUR LESS FREQUENTLY. /DINOPROST TROMETHAMINE/

BRONCHOSPASM...IN...ASTHMATIC PT; GRAND MAL CONVULSIONS...OCCUR...IN PT PRONE TO EPILEPSY. VASOMOTOR REACTIONS, ARRHYTHMIAS, ATRIOVENTRICULAR CONDUCTION DISTURBANCES, HYPERVENTILATION, PARESTHESIAS & HYPERESTHESIAS, CHEST PAIN, HICCUPS, & DYSURIA HAVE BEEN OBSERVED AFTER INTRAUTERINE ADMIN... /DINOPROST TROMETHAMINE/

化学と産業

薬理情報

ATC Code · 2 件

G - Genito urinary system and sex hormones

QG - Genito urinary system and sex hormones

Mechanism of Action · 4 件

...THERE IS NO SINGLE PROSTAGLANDIN RECEPTOR. ... IT IS POSSIBLE TO DEMONSTRATE CALCIUM DEPENDENCE OF DIVERSE RESPONSES TO PROSTAGLANDINS & TO OBSERVE ALTERED CALCIUM FLUXES. ...PROSTAGLANDINS MAY EITHER STIMULATE OR INHIBIT ACCUM OF CYCLIC AMP. /PROSTAGLANDINS/

RESPONSES TO PROSTAGLANDIN F2ALPHA SHOW SPECIES VARIATION, BUT VASODILATATION HAS BEEN OBSERVED FOLLOWING INJECTION INTO HUMAN BRACHIAL ARTERY OF PGF2ALPHA... SUPERFICIAL VEINS OF HAND ARE CONTRACTED BY PFG2ALPHA...

PROMPT SUBSIDENCE OF PROGESTERONE OUTPUT & REGRESSION OF CORPUS LUTEUM FOLLOWS PARENTERAL INJECTION OF PROSTAGLANDIN F2ALPHA... THIS EFFECT INTERRUPTS EARLY PREGNANCY, WHICH IS DEPENDENT ON LUTEAL RATHER THAN PLACENTAL PROGESTERONE.

OXYTOCIN & PROSTAGLANDINS AFFECT UTERINE SMOOTH MUSCLES BY DIFFERENT MECHANISMS, & THEIR EFFECTS ARE ADDITIVE. POSSIBLE ADVANTAGES OF THEIR COMBINED USE ARE BEING EXPLORED. /PROSTAGLANDINS/

Metabolism/Metabolites...PROSTAGLANDINS ARE RAPIDLY METABOLIZED... /PROSTAGLANDINS/
MeSH Pharmacological Classification · 2 件

Non-steroidal chemical compounds with abortifacient activity.

Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157)

Absorption, Distribution and Excretion · 3 件

AMONG COMPD OCCURRING IN SEMEN THAT ARE OF CURRENT RESEARCH INTEREST ARE PROSTAGLANDINS (25 MG/ML). /PROSTAGLANDINS/

APART FROM GENERALLY SLOW & SPECIES-DEPENDENT ISOMERIZATION, PGS E & F ARE RATHER STABLE IN BLOOD, BUT THEY ARE RAPIDLY DEGRADED & INACTIVATED BY TISSUE-BOUND ENZYMES; SOME 80-90% OR MORE IS DESTROYED DURING SINGLE PASSAGE THROUGH LIVER OR LUNGS. /PROSTAGLANDINS/

関連反応

39 件
反応記録を作成
HRID 55777 の反応式
HRID 55777反応物として
HRID 258642 の反応式
HRID 258642反応物として
HRID 328230 の反応式
HRID 328230反応物として
HRID 436951 の反応式
HRID 436951反応物として
HRID 437096 の反応式
HRID 437096生成物として
HRID 456801 の反応式
HRID 456801反応物として
HRID 477215 の反応式
HRID 477215反応物として
HRID 613944 の反応式
HRID 613944反応物として
前へ1 / 5 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
PubChem CID
5280363
DTXSID
DTXSID9022946
ChEMBL
CHEMBL815
ChEBI
CHEBI:15553
UNII
B7IN85G1HY
EC Number
684-259-0
Nikkaji
J9.246K

205.7 Ų [M+Na]+ [CCS Type: DT; Method: stepped-field]

204.4 Ų [M+Na]+

Other Experimental Properties · 3 件

ODORLESS, BITTER-TASTING /DINOPROST TROMETHAMINE/

MP APPROX 100 °C /DINOPROST TROMETHAMINE/

WHITE OR OFF-WHITE CRYSTALLINE POWDER /DINOPROST TROMETHAMINE/

物理化学的性質

沸点
407.69 °C · 407.69°C (rough estimate)
比重(密度)
1.0458 · 1.0458 (rough estimate)
屈折率
1.612 · 1.6120 (estimate)
貯蔵温度
-20 °C · -20°C
酸解離定数(Pka)
4.76 · 4.76±0.10(Predicted)

For more Human Toxicity Excerpts (Complete) data for PROSTAGLANDIN F2ALPHA (6 total), please visit the HSDB record page.

Non-Human Toxicity Excerpts · 1 件

IN PREGNANT RATS TREATED SC @ 50 UG, DAYS 9-11 OR 12-15 OF GESTATION, PLACENTA SHOWED EXTENSIVE AREAS OF DEGENERATION THAT ARE FOUND IN PLACENTAL INSUFFICIENCY. ALSO FETAL ADRENAL CORTEX SHOWED MORPHOLOGICAL CHANGES INDICATIVE OF INTRAUTERINE DISTRESS.

Antidote and Emergency TreatmentSINCE DINOPROST IS METABOLIZED RAPIDLY, DISCONTINUATION OF DRUG & SUPPORTIVE THERAPY ARE ADEQUATE TREATMENT...BLOOD TRANSFUSIONS MAY BE REQUIRED /FOR HEMORRHAGE DUE TO RETENTION OF PLACENTA/

安全データ

risk_code
20-35
hazard_code
C
safety_code
26-36/37/39-45

DEG OF BINDING OF PROSTAGLANDINS TO PLASMA PROTEINS APPEARS TO HAVE LITTLE INFLUENCE ON THEIR RATES OF METABOLISM & ELIMINATION. ... CLEARANCE RATES OF (3)H DID NOT CHANGE WHETHER PROSTAGLANDINS WERE ADMIN IN FREE FORM OR BOUND TO RAT PLASMA ALBUMIN. /PROSTAGLANDINS/

用途と製造

Uses · 2 件

MEDICATION (VET)

MEDICATION

Methods of Manufacturing...SYNTH OF NATURAL PROSTAGLANDIN F2ALPHA: SCHNEIDER, MURRAY, J ORG CHEM 38, 397 (1973).
Formulations/Preparations...SOLN CONTAINING EQUIV OF 5 MG OF PROSTAGLANDIN F2ALPHA PER MILLILITER; IT IS AVAIL IN 4- & 8-ML AMPULS FOR INTRA-AMNIOTIC ADMIN TO INDUCE ABORTION.
General Manufacturing Information · 5 件

...20-CARBON UNSATURATED CARBOXYLIC ACIDS WITH CYCLOPENTANE RING. ...KINSHIP WITH ESSENTIAL FATTY ACIDS... MAIN CLASSES--E, F, A, B, C, & D-DISTINGUISHED BY CONSTITUENTS OF...RING. ...SUBDIVIDED...WITH NUMBER OF DOUBLE BONDS IN SIDE CHAINS. ...INDICATED BY SUBSCRIPT...REFLECTS FATTY ACID PRECURSOR. /PROSTAGLANDINS/

PROSTAGLANDINS OF E & FALPHA SERIES ARE SOMETIMES REFERRED TO AS "PRIMARY PROSTAGLANDINS". ...MOST ABUNDANT (ESP E2 & F2ALPHA)... /PROSTAGLANDINS/

IN VIVO MOST CELLS SEEM CAPABLE OF SYNTHESIZING PROSTAGLANDINS FROM ESSENTIAL FATTY ACID PRECURSORS. ...BELIEVED THAT ENDOGENOUS BIOSYNTHESIS, IN ABSENCE OF ADDED PRECURSOR ACID, DEPENDS ON PHOSPHOLIPASE-CATALYZED RELEASE OF PRECURSOR ACID FROM CELLULAR PHOSPHOLIPID STORES. /PROSTAGLANDINS/

SYNTH OF PRIMARY PROSTAGLANDINS...BY COMPLEX OF MICROSOMAL ENZYMES REFERRED TO AS "PROSTAGLANDIN SYNTHETASE." INITIAL EVENTS...RESULT IN OXYGENATION & CYCLIZATION OF UNESTERIFIED PRECURSOR ACID TO FORM CYCLIC PEROXIDE DERIV. ...ENDOPEROXIDE IS...REDUCED, YIELDING PGFALPHA COMPD. /PROSTAGLANDINS/

MOST PROLIFIC SOURCE OF NATURAL PROSTAGLANDINS IS MARINE ORGANISM CALLED GORGONIAN SEA WHIP, WHICH OCCURS...IN CORAL REEFS, ESP IN CARIBBEAN AREA. HARVESTING OF THESE HAS MADE PRODN...MUCH LESS EXPENSIVE. INTERMEDIATES & CHEM ANALOGS DERIVED FROM THIS NATURAL SOURCE...SYNTONS. /PROSTAGLANDINS/